Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/82633, first published .
Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Effectiveness and Safety of a Supplement Containing a Pharmacologically Active Basidiomycete Mushroom for Chronic Fatigue and Post–COVID-19 Fatigue Syndrome: Protocol for a Randomized Controlled Trial

Yunqing Xun   1 , MSc ;   Tung Leong Fong   1 , MSc ;   Guang Chen   1 , Ph.D. ;   Yibin Feng   1 , Prof Dr ;   Linda Chan   1, 2, 3, 4 , Prof Dr ;   Ning Wang   1 , Prof Dr Med

1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)

2 Bau Institute of Medical and Health Sciences Education, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)

3 Department of Family Medicine and Primary Care, The University of Hong Kong-Shenzhen Hospital, Hong Kong, China (Hong Kong)

4 School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China (Hong Kong)

Corresponding Author:

  • Ning Wang, Prof Dr Med
  • School of Chinese Medicine
  • Li Ka Shing Faculty of Medicine
  • The University of Hong Kong
  • School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • Hong Kong
  • China (Hong Kong)
  • Phone: 852 3917 6441
  • Email: ckwang@hku.hk